Condition: Cardiovascular Diseases (CVD) · Type 2 Diabetes · Chronic Respiratory Diseases · Sponsor: Asfendiyarov Kazakh National Medical University
This study aims to enhance personalized and preventive care for non-communicable diseases (NCDs) in Kazakhstan by examining epigenetic factors, predicting biological age and reproductive function using machine learning, and developing health improvement recommendations.
This description comes directly from the study's public registry record.
Ildar Fakhradiyev, Ph.D · +7 (727) 338 7090 · fakhradiyev.i@kaznmu.kz
Always discuss trial participation with your own doctor first.
| Asfendiyarov Kazakh National Medical University | Almaty, Kazakhstan, Kazakhstan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06953180